Center for Theoretical Problems of Physico-Chemical Pharmacology, Russian Academy of Sciences, Moscow, Russia; Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
Computer Science Department, University of Geneva, Carouge, Switzerland.
Biophys J. 2020 Aug 4;119(3):638-651. doi: 10.1016/j.bpj.2020.06.020. Epub 2020 Jun 26.
The fibrin clot is gelatinous matter formed upon injury to stop blood loss and is later destroyed by fibrinolysis, an enzymatic cascade with feedback. Pharmacological fibrinolysis stimulation is also used to destroy pathological, life-threatening clots and thrombi (thrombolysis). The regulation of the nonlinear spatially nonuniform fibrinolytic process in thrombolysis is not currently well understood. We developed a reaction-diffusion-advection model of thrombolysis by tissue plasminogen activator (TPA) in an occluded vessel with a pressure gradient. Sensitivity-analysis-based model reduction was used to reveal the critical processes controlling different steps of thrombolysis. The propagation of thrombolysis in the system without flow was predominantly controlled by TPA diffusion, whereas transport of other active components was rendered nonessential either by their high fibrin-binding parameters and short lifetimes or their initial uniform distribution. The concentration of the main TPA inhibitor plasminogen activator inhibitor 1 (PAI-1) controlled both the extent of lysis propagation and the shape of fibrin spatial distribution during lysis. Interestingly, PAI-1 remained important even when its concentration was an order of magnitude below that of TPA because of its role at the edge of the diffusing TPA front. The system was robust to reaction rate constant perturbations. Using these data, a reduced model of thrombolysis was proposed. In the presence of flow, convection of TPA was the critical controlling process; although the role of PAI-1 concentration was much less in the presence of flow, its influence became greater in the presence of collateral bypassing vessels, which sufficiently reduced TPA flux through the thrombus. Flow bypass through the collateral vessel caused a decrease in TPA flux in the clotted vessel, which increased the PAI-1/TPA ratio, thus making PAI-1-induced inhibition relevant for the regulation of spatial lysis up to its arrest.
纤维蛋白凝块是受伤时形成的凝胶状物质,用于止血,随后被纤维蛋白溶解(一种具有反馈的酶级联反应)破坏。药理学纤维蛋白溶解刺激也用于破坏病理性、危及生命的血栓(溶栓)。目前,对溶栓过程中非线性空间不均匀纤维蛋白溶解的调节还不是很了解。我们在存在压力梯度的闭塞血管中,用组织型纤溶酶原激活物(tissue plasminogen activator,TPA)开发了一个溶栓的反应-扩散-对流模型。基于敏感性分析的模型降阶用于揭示控制溶栓不同步骤的关键过程。在没有流动的系统中,溶栓的传播主要由 TPA 扩散控制,而其他活性成分的输送要么由于其与纤维蛋白的高结合参数和短寿命,要么由于其初始均匀分布而变得不重要。主要的 TPA 抑制剂纤溶酶原激活物抑制剂 1(plasminogen activator inhibitor 1,PAI-1)的浓度控制了纤溶过程中溶解释放的程度和纤维蛋白空间分布的形状。有趣的是,即使 PAI-1 的浓度比 TPA 低一个数量级,由于其在扩散 TPA 前沿的边缘的作用,PAI-1 仍然很重要。该系统对反应速率常数的摄动具有鲁棒性。利用这些数据,提出了一个简化的溶栓模型。在存在流动的情况下,TPA 的对流是关键控制过程;尽管在存在流动的情况下,PAI-1 浓度的作用要小得多,但在存在旁路血管的情况下,其影响会更大,这会降低 TPA 通过血栓的通量。旁路血管的血流绕过引起血栓内的 TPA 通量减少,这增加了 PAI-1/TPA 比值,从而使 PAI-1 诱导的抑制作用与空间溶解的调节相关,直至其停止。